Lpl Financial LLC Sarepta Therapeutics, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 47,543 shares of SRPT stock, worth $5.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,543
Previous 45,480 4.54%
Holding current value
$5.43 Million
Previous $7.19 Million 17.36%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$124.33 - $156.75 $256,492 - $323,375
2,063 Added 4.54%
47,543 $5.94 Million
Q2 2024

Aug 07, 2024
BUY
$113.33 - $163.85 $1.49 Million - $2.15 Million
13,114 Added 40.52%
45,480 $7.19 Million
Q1 2024

May 10, 2024
BUY
$93.7 - $141.53 $396,163 - $598,388
4,228 Added 15.03%
32,366 $4.19 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $8,481 - $15,719
126 Added 0.45%
28,138 $2.71 Million
Q3 2023

Nov 13, 2023
SELL
$102.5 - $123.59 $376,687 - $454,193
-3,675 Reduced 11.6%
28,012 $3.4 Million
Q2 2023

Jul 31, 2023
BUY
$106.4 - $157.19 $326,435 - $482,258
3,068 Added 10.72%
31,687 $3.63 Million
Q1 2023

May 10, 2023
BUY
$117.53 - $155.99 $343,540 - $455,958
2,923 Added 11.38%
28,619 $3.94 Million
Q4 2022

Feb 07, 2023
SELL
$100.86 - $132.13 $165,612 - $216,957
-1,642 Reduced 6.01%
25,696 $3.33 Million
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $106,221 - $167,293
-1,403 Reduced 4.88%
27,338 $3.02 Million
Q2 2022

Aug 12, 2022
SELL
$62.69 - $88.44 $77,171 - $108,869
-1,231 Reduced 4.11%
28,741 $2.15 Million
Q1 2022

May 16, 2022
BUY
$63.15 - $90.42 $70,601 - $101,089
1,118 Added 3.87%
29,972 $2.34 Million
Q4 2021

Feb 14, 2022
SELL
$77.28 - $99.42 $215,456 - $277,182
-2,788 Reduced 8.81%
28,854 $2.6 Million
Q3 2021

Nov 15, 2021
BUY
$65.97 - $92.48 $369,761 - $518,350
5,605 Added 21.53%
31,642 $2.93 Million
Q2 2021

Aug 13, 2021
BUY
$69.38 - $86.75 $289,106 - $361,487
4,167 Added 19.05%
26,037 $2.02 Million
Q1 2021

May 14, 2021
BUY
$72.25 - $168.95 $115,238 - $269,475
1,595 Added 7.87%
21,870 $1.63 Million
Q4 2020

Feb 12, 2021
SELL
$125.56 - $178.74 $17,955 - $25,559
-143 Reduced 0.7%
20,275 $3.46 Million
Q3 2020

Nov 09, 2020
BUY
$127.12 - $172.34 $71,822 - $97,372
565 Added 2.85%
20,418 $2.87 Million
Q2 2020

Aug 13, 2020
BUY
$93.0 - $171.7 $122,388 - $225,957
1,316 Added 7.1%
19,853 $3.18 Million
Q1 2020

May 14, 2020
BUY
$82.38 - $131.64 $599,067 - $957,286
7,272 Added 64.55%
18,537 $1.81 Million
Q4 2019

Feb 14, 2020
SELL
$76.53 - $135.58 $337,420 - $597,772
-4,409 Reduced 28.13%
11,265 $1.45 Million
Q3 2019

Nov 13, 2019
SELL
$72.81 - $156.91 $67,931 - $146,397
-933 Reduced 5.62%
15,674 $1.18 Million
Q2 2019

Aug 09, 2019
BUY
$112.21 - $151.95 $384,655 - $520,884
3,428 Added 26.01%
16,607 $2.52 Million
Q1 2019

May 08, 2019
BUY
$106.67 - $151.68 $89,816 - $127,714
842 Added 6.82%
13,179 $1.57 Million
Q4 2018

Feb 07, 2019
SELL
$97.32 - $148.76 $234,833 - $358,957
-2,413 Reduced 16.36%
12,337 $1.35 Million
Q3 2018

Nov 14, 2018
BUY
$115.31 - $161.51 $135,604 - $189,935
1,176 Added 8.66%
14,750 $2.38 Million
Q2 2018

Aug 14, 2018
BUY
$71.74 - $153.69 $71,381 - $152,921
995 Added 7.91%
13,574 $1.79 Million
Q1 2018

May 15, 2018
BUY
$54.02 - $82.27 $55,100 - $83,915
1,020 Added 8.82%
12,579 $932,000
Q4 2017

Feb 14, 2018
BUY
$47.64 - $56.75 $550,670 - $655,973
11,559
11,559 $643,000

Others Institutions Holding SRPT

# of Institutions
531
Shares Held
84.5M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email